FDA Inspection 805932 — Moore Clinical Research Inc.

Moore Clinical Research Inc. — FEI 3007748961

The FDA completed an inspection of Moore Clinical Research Inc. on Oct 18, 2012 in Brandon, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 18, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Brandon, FL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance